M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.

The importance of acetylcholine as a neurotransmitter in the nervous system is well established, but little is yet known about its recently described role as an autocrine and paracrine hormone in a wide variety of nonneuronal cells. Consistent with the expression of acetylcholine in normal lung, small cell lung carcinoma (SCLC) synthesize and secrete acetylcholine, which acts as an autocrine growth factor through both nicotinic and muscarinic cholinergic mechanisms. The purpose of this study was to determine if interruption of autocrine muscarinic cholinergic signaling has potential to inhibit SCLC growth. Muscarinic receptor (mAChR) agonists caused concentration-dependent increases in intracellular calcium and mitogen-activated protein kinase (MAPK) and Akt phosphorylation in SCLC cell lines. The inhibitory potency of mAChR subtype-selective antagonists and small interfering RNAs (siRNAs) on acetylcholine-increased intracellular calcium and MAPK and Akt phosphorylation was consistent with mediation by M3 mAChR (M3R). Consistent with autocrine acetylcholine secretion stimulating MAPK and Akt phosphorylation, M3R antagonists and M3R siRNAs alone also caused a decrease in basal levels of MAPK and Akt phosphorylation in SCLC cell lines. Treatment of SCLC cells with M3R antagonists inhibited cell growth both in vitro and in vivo and also decreased MAPK phosphorylation in tumors in nude mice in vivo. Immunohistochemical staining of SCLC and additional cancer types showed frequent coexpression of acetylcholine and M3R. These findings suggest that M3R antagonists may be useful adjuvants for treatment of SCLC and, potentially, other cancers.

[1]  N. Gross.  Anticholinergic agents in asthma and COPD. , 2006, European journal of pharmacology.

[2]  F. Ruíz-Espejo,et al.  Cholinesterase activity of human lung tumours varies according to their histological classification. , 2006, Carcinogenesis.

[3]  S. Hegde.  Muscarinic receptors in the bladder: from basic research to therapeutics , 2006, British journal of pharmacology.

[4]  L. Kunz,et al.  A non-neuronal cholinergic system of the ovarian follicle. , 2005, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[5]  D. Jackman,et al.  Small-cell lung cancer , 2005, The Lancet.

[6]  E. Jiménez,et al.  Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells , 2005, Journal of cellular physiology.

[7]  J. Changeux,et al.  Nicotine Upregulates Its Own Receptors through Enhanced Intracellular Maturation , 2005, Neuron.

[8]  W. Kummer,et al.  Expression of the cholinergic gene locus in the rat placenta , 2004, Histochemistry and Cell Biology.

[9]  E. Spindel,et al.  Prenatal nicotine exposure increases connective tissue expression in foetal monkey pulmonary vessels , 2004, European Respiratory Journal.

[10]  R. Blakely,et al.  Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. , 2004, Endocrinology.

[11]  P. Dennis,et al.  Preferential inhibition of Akt and killing of Akt-dependent cancer cells by rationally designed phosphatidylinositol ether lipid analogues. , 2004, Cancer research.

[12]  C. Harris,et al.  Tobacco Carcinogen-Induced Cellular Transformation Increases Activation of the Phosphatidylinositol 3′-Kinase/Akt Pathway in Vitro and in Vivo , 2004, Cancer Research.

[13]  P. Granone,et al.  α7-Nicotinic Acetylcholine Receptors Affect Growth Regulation of Human Mesothelioma Cells , 2004, Cancer Research.

[14]  K. Mitamura,et al.  Growth-promoting effect of muscarinic acetylcholine receptors in colon cancer cells , 2003, Journal of Cancer Research and Clinical Oncology.

[15]  J. Raufman,et al.  Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells. , 2003, Cancer research.

[16]  K. Kawashima,et al.  The lymphocytic cholinergic system and its biological function. , 2003, Life sciences.

[17]  S. Grando,et al.  Muscarinic acetylcholine receptors regulating cell cycle progression are expressed in human gingival keratinocytes. , 2003, Journal of periodontal research.

[18]  P R Sanberg,et al.  Mecamylamine (Inversine®): an old antihypertensive with new research directions , 2002, Journal of Human Hypertension.

[19]  U. Drews,et al.  Muscarinic receptors in cell lines from ovarian carcinoma: negative correlation with survival of patients. , 2002, Gynecologic oncology.

[20]  R. Proctor.  Tobacco and the global lung cancer epidemic , 2001, Nature Reviews Cancer.

[21]  Fernando Bittinger,et al.  Release of non-neuronal acetylcholine from the human placenta: difference to neuronal acetylcholine , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[22]  T. Möller,et al.  Activation of mitogen‐activated protein kinase by muscarinic receptors in astroglial cells: Role in DNA synthesis and effect of ethanol , 2001, Glia.

[23]  L. Costa,et al.  Activation of phosphatidylinositol 3 kinase by muscarinic receptors in astrocytoma cells , 2001, Neuroreport.

[24]  W. Kummer,et al.  Expression of the cholinergic gene locus in pulmonary arterial endothelial cells , 2000, Histochemistry and Cell Biology.

[25]  H. Plummer,et al.  Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders. , 2000, European journal of pharmacology.

[26]  R. Jensen,et al.  Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  M. Kodaira,et al.  Functional muscarinic m3 receptor expressed in gastric cancer cells stimulates tyrosine phosphorylation and MAP kinase , 1999, Journal of Gastroenterology.

[28]  P. Bunn,et al.  Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth. , 1998, Cancer research.

[29]  K. Racké,et al.  Mammalian glial cells in culture synthesize acetylcholine , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[30]  C. Kirkpatrick,et al.  Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[31]  W. Rayford,et al.  Muscarinic cholinergic receptors promote growth of human prostate cancer cells , 1997, The Prostate.

[32]  M. Napolitano,et al.  Cholinergic stimulation of human microcytoma cell line H69. , 1997, Biochemical and biophysical research communications.

[33]  K. Racké,et al.  Acetylcholine in isolated airways of rat, guinea pig, and human: species differences in role of airway mucosa. , 1996, The American journal of physiology.

[34]  L. Costa,et al.  Acetylcholine as a mitogen: muscarinic receptor-mediated proliferation of rat astrocytes and human astrocytoma cells. , 1996, European journal of pharmacology.

[35]  J. Minna,et al.  Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[36]  J. Patrick,et al.  α-Bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line , 1994, Brain Research.

[37]  I. Morita,et al.  Phorbol ester stimulates acetylcholine synthesis in cultured endothelial cells isolated from porcine cerebral microvessels , 1994, Brain Research.

[38]  D. Kist,et al.  Human keratinocytes synthesize, secrete, and degrade acetylcholine. , 1993, The Journal of investigative dermatology.

[39]  P. Whiting,et al.  Brain α-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily , 1990, Neuron.

[40]  G. Kalemkerian,et al.  Small cell lung cancer , 2010, Seminars in Respiratory and Critical Care Medicine.

[41]  A. Fassoulaki,et al.  Serum Cholinesterase Levels in Patients with Cancer , 1979, Anesthesia and analgesia.

[42]  Y. Oshika,et al.  P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. , 1996, British Journal of Cancer.

[43]  A. Skerjanec.  The Clinical Pharmacokinetics of Darifenacin , 2006, Clinical pharmacokinetics.

[44]  P. Granone,et al.  Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. , 2004, Cancer research.

[45]  J. Blusztajn,et al.  Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. , 2003, Cancer research.

[46]  C. Harris,et al.  Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. , 2003, The Journal of clinical investigation.

[47]  H. Plummer,et al.  Receptor-mediated effects of nicotine and its nitrosated derivative NNK on pulmonary neuroendocrine cells. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[48]  R. Breitling,et al.  Expression of muscarinic receptor types in the primate ovary and evidence for nonneuronal acetylcholine synthesis. , 2001, The Journal of clinical endocrinology and metabolism.

[49]  C. Kirkpatrick,et al.  Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. , 1998, Pharmacology & therapeutics.

[50]  J. Minna,et al.  NCI‐navy medical oncology branch cell line data base , 1996, Journal of cellular biochemistry. Supplement.

[51]  J. Wess.  Molecular biology of muscarinic acetylcholine receptors. , 1996, Critical reviews in neurobiology.